Antigen-pulsed dendritic cell vaccine (Musashino University)

N/A

Report date: 2023/06/26 09:15:25

Base Information

Drug NameAntigen-pulsed dendritic cell vaccine (Musashino University)

Drug Alias Nameantigen-pulsed dendritic cell vaccine (pancreatic cancer)

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesMusashino University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMusashino University

Active IndicationsN/A

Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A